Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015)
Clinical trial NCT01697592 · COMPLETED
Trial details
- NCT number
- NCT01697592
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-24
- Primary completion
- 2014-05-08
- Enrollment
- 585
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.